Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DuP-753

Known as: DuP 753, DuP753 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
Nuclear factor-kappaB (NF-kappaB) regulates many genes involved in vascular physiopathology. We have previously observed in vivo… Expand
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • figure 5
Review
1998
Review
1998
Angiotensin (ANG) II is a powerful and phylogenetically widespread stimulus to thirst and sodium appetite. When it is injected… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
1997
Highly Cited
1997
Angiotensin II stimulates secretion of corticosteroids and ouabain-like activity from adrenocortical cells. Distinct… Expand
  • figure 3
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Highly Cited
1994
Highly Cited
1994
OBJECTIVE The aim was to determine angiotensin II receptor binding and its relationship to angiotensin converting enzyme (ACE… Expand
Highly Cited
1993
Highly Cited
1993
Excessive secretion of aldosterone from the adrenal results in the most common form of endocrine hypertension. An understanding… Expand
Highly Cited
1993
Highly Cited
1993
Aspartic acid in the second transmembrane domain is a highly conserved amino acid among the G protein-coupled receptors and is… Expand
Highly Cited
1993
Highly Cited
1993
The present research characterizes a newly discovered ANG II(3-8) (ANG IV) binding site localized in structures associated with… Expand
Highly Cited
1993
Highly Cited
1993
Starting from the recently reported nonpeptidic angiotensin II (AII) receptor antagonists DuP753 (1) and Exp 7711 (2), we have… Expand
Highly Cited
1991
Highly Cited
1991
Both neurons and astrocytes contain specific receptors for angiotensin II (AII). We used selective ligands for the AT1 and AT2… Expand
Review
1991
Review
1991
Substantial progress has been made recently in the development of nonpeptide angiotensin II receptor antagonists, a goal that has… Expand